BIOLIFE SOLUTIONS INC
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 2. PROPERTIES
Our material office and manufacturing leases are detailed below:
| Location | Square Feet | Principal Use | Lease Expiration |
|---|---|---|---|
| Bothell, WA | 45,522 | Corporate headquarters, manufacturing, research and development, marketing, and administrative offices | July 2031 |
| Woodinville, WA | 13,578 | Warehouse | January 2030 |
| Albuquerque, NM | 2,940 | Research and development and administrative offices | April 2027 |
| Bruce Township, MI | 106,998 | Manufacturing, research and development, and administrative offices | Month to Month |
| Athens, OH | 50,000 | Manufacturing, research and development, and administrative offices | March 2028 |
| Nelsonville, OH | 24,114 | Warehouse | June 2024 |
| Columbus, OH | 1,807 | Administrative offices | January 2025 |
| Indianapolis, IN | 11,415 | Manufacturing, research and development, and administrative offices | September 2024 |
| United States | 12,500 | Biological and pharmaceutical specimen storage | January 2027 |
| United States | 26,600 | Biological and pharmaceutical specimen storage | March 2024 |
| United States | 16,153 | Biological and pharmaceutical specimen storage | June 2024 |
| United States | 16,800 | Biological and pharmaceutical specimen storage | February 2026 |
| United States | 26,800 | Biological and pharmaceutical specimen storage | November 2031 |
| Netherlands | 47,533 | Biological and pharmaceutical specimen storage | March 2026 |
We consider the facilities to be in a condition suitable for their current uses. Because of anticipated growth in the business and due to the increasing requirements of customers or regulatory agencies, we may need to acquire additional space or upgrade and enhance existing space. We believe that adequate facilities will be available upon the conclusion of our leases.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.